-

MetLife Opens InterContinental Times Square to COVID-19 Healthcare Workers

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET), which owns a majority stake in the InterContinental Times Square, today announced that it will open 250 rooms to healthcare workers on the front lines of the fight against COVID-19.

MetLife will offer free housing at the hotel for nurses, doctors and other medical workers effective immediately. Visiting medical professionals, once they have been assigned to a New York hospital by New York’s healthcare authorities, will be provided with credentials to book directly at the hotel. This process is being coordinated by the state of New York and the Hotel Association of New York City.

“Throughout MetLife’s history, we’ve worked with nurses and doctors to promote the nation’s health, including our partnership with the Visiting Nurse Association,” said Mike Zarcone, Executive Vice President and head of Corporate Affairs at MetLife. “Now more than ever they are the backbone of our healthcare system, and society is depending on them to help keep us safe. We are honored to help.”

MetLife’s close association with the healthcare profession dates to 1909, when the company began its visiting nurses program that sent nurses to the homes of low-income customers to care for the sick and teach modern hygiene. MetLife’s agents would notify the Visiting Nurse Association when a family needed help.

MetLife has been headquartered in New York City since its founding in 1868. In addition to MetLife’s corporate support, MetLife Foundation is donating $300,000 to New York-area food banks to help them deal with increased demand for their services as a result of coronavirus. This giving is part of a larger $25 million commitment MetLife Foundation announced on March 31 to help with the global response to COVID-19.

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Contacts

Liz Harish, 929-343-7473

MetLife, Inc.

NYSE:MET

Release Versions

Contacts

Liz Harish, 929-343-7473

More News From MetLife, Inc.

MetLife Names Jordan Canter Head of Federal Government Affairs and Regulatory Policy

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) announced that Jordan Canter will join as head of Federal Government Affairs and Regulatory Policy, effective April 20. She will oversee MetLife’s federal government affairs and global regulatory policy, collaborating with internal and external stakeholders to support the company’s business priorities. Based in Washington, D.C., Canter will report to Susan Greenwell, senior vice president and head of Global Government Affairs. “As the policy...

MetLife Study Finds AI Acceleration Is Creating New Concerns in Today’s Workplace

NEW YORK--(BUSINESS WIRE)--As the adoption of artificial intelligence (AI) in the workplace accelerates, MetLife’s 24th Annual U.S. Employee Benefit Trends Study (EBTS) reveals, alongside other findings, a workforce both optimistic about the technology’s efficiency gains and concerned about how technological change is reshaping work, well‑being and long‑term security. MetLife’s 2026 EBTS, released today, shows that AI is already deeply embedded in everyday work: 80% of employers say AI tools ar...

MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 10,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.002 percent of MetLife shares of common stock outstanding as of February 12, 2026. Potemkin’s offer price of $51.60 per share is approximately 27.09 percent lower than the $70.77 closing price of MetLife common...
Back to Newsroom